Vanderbilt Research Could Redefine Alzheimer's Treatment
More than five million Americans are living with Alzheimer's disease, a diagnosis that kills more people yearly than.... Read More
A study published last month in the journal Schizophrenia Bulletin found the death rate in young people during the year following a first episode psychosis incidence was much.... Read More
In late December, Vanderbilt University scientists received the green light from the U.S. Food and Drug Administration (FDA) to proceed to clinical testing in humans for an in.... Read More